SSc-PAH: Systemic sclerosis with pulmonary arterial hypertension IGH: immunoglobulin heavy-chain BCR: B-cell receptor CDR3: complementarity-determining region 3
Introduction
Systemic sclerosis (SSc), or scleroderma, is a rare chronic autoimmune disease leading to tissue fibrosis and vasculopathy (1) . Indications of a dysregulated immune system include reduced lymphocyte counts (2), T-cell anomalies (3) and B-cell anomalies, in particular the presence of autoantibodies (4) , increased CD19 expression (5), increased naïve B-cell proportions and diminished memory B-cell proportions (5) . A complication with particularly poor prognosis is pulmonary arterial hypertension (PAH) (6) , which can arise from SScassociated interstitial lung disease (ILD), but also directly from SSc without significant ILD; the latter case, which we will refer to as SSc-PAH, is the object of the present study. Current treatment typically focuses on pulmonary vasodilation and is not curative (7) . Immunotherapy with the B-cell depleting agent rituximab, a monoclonal antibody against CD20 (8, 9) , has shown promise as a potential treatment for some forms of SSc, improving disability scores (10) and lung function (11) , but has not previously been assessed in controlled multicenter clinical trials for SSc-PAH. The B-cell basis of SSc has previously been studied (12) at the level of subset sizes (5), cytokine levels (13), response regulators (5, 14) and autoantibody specificities (15, 16) , but not at the level of sequence-based B-cell phylogeny. Reconstitution of the immunoglobulin heavy-chain repertoire following rituximab administration has been studied before (17) , but sample size was small (2 participants) and sequencing depth was low (on the order of 680 sequences).
Here, we elucidate signatures of SSc-PAH and dynamics of B-cell replenishment after depletion using massively parallel sequencing of immunoglobulin heavy-chain (IGH) transcripts found in peripheral-blood mononuclear cells ("antibody repertoire sequencing"), which provides a wealth of information on the processes of VDJ recombination, clonal expansion, somatic hypermutation and isotype-switching that shape the B-cell repertoire (18, 19) . We longitudinally studied 11 participants from an ongoing randomized, double-blind, placebo-controlled phase II multicenter trial of rituximab for the treatment of SSc-PAH, sequencing 85 samples and obtaining > 4 million IGH sequences. Infusions of 1000 mg of rituximab or a placebo were given at weeks 0 and 2; blood was sampled at baseline (pre-infusion), at weeks 2 and 4 relative to the first infusion, and roughly in 12-week increments after that (Fig. 1A) . All SSc-PAH participants were females between the ages of 48 and 73, inclusive; healthy baseline controls were 15 females between the ages of 50 and 75, inclusive (Suppl. Table S1 ).
Results

Identification of a study group undergoing B-cell depletion
Since the clinical trial providing study samples is ongoing, it is blinded as to whether study arm A or B corresponded to the rituximab group as opposed to placebo (Fig. 1A) . Here, we show that the characteristics of group A are consistent with CD20 + B-cell depletion. Indeed, group A shows a transient reduction in overall B-cell receptor (BCR) diversity ( early post-infusion time points, it is clear that subjects cluster into an unaffected and an affected group (Fig. 1E) . In order to compare the initial B-cell repertoire to the reconstituted repertoire after depletion, we applied the phylogenetic distance metric UniFrac (21) whose use on immune repertoire data was recently demonstrated (22) . As expected, we found that group A displayed greater pre-to-post-infusion distances than group B (Fig. 1F) , consistent with repertoire reconstitution by a fresh set of naïve B-cells not clonally related to the baseline population.
These observations establish group A as a cohort that can be used to study B-cell depletion.
B-cell signatures of SSc-PAH
The hypervariable complementarity-determining region 3 (CDR3) of antibodies is a key determinant of antigen specificity (23) . Antibody repertoire analysis has been used to search for convergent CDR3 sequences characterizing the immune response to certain infectious agents, notably dengue virus (24) . To investigate which antibodies may be responsible for autoimmunity
in systemic sclerosis, we tested all CDR3 amino acid sequences identified in this study, together with their one-mismatch derivatives, for enrichment in the SSc-PAH cohort versus the healthy cohort (Fisher Exact Tests with Benjamini-Hochberg correction). No sequences displayed a statistically significant association with SSc-PAH (Suppl. Fig. S1A,B ). This negative result may be due to limited statistical power or undersampling of the repertoire, but also to biological idiosyncrasy: the relevant autoantigen(s) may differ from participant to participant and antibodies binding any given autoantigen may be encoded by distinct amino acid sequences.
We may nevertheless gain insight into the disease by studying the global structure of the antibody repertoire rather than individual antibody sequences. SSc-PAH participants tended to display slightly lower overall BCR diversity (Suppl. Fig. S1C ), a higher proportion of IgD diversity and lower mean mutation loads in IgD than healthy subjects ( Fig. 2A) , consistent with previous reports of reduced lymphocyte counts (2) and expanded naïve B-cell proportions (5).
This finding constitutes evidence for altered B-cell homeostatic mechanisms.
It has also been reported that memory B-cells are reduced in number but activated in scleroderma (5). Here, we are able to obtain further insight into the anomalies of the antigenexperienced compartment. We found that the average expression of distinct BCRs was higher in SSc-PAH (Fig. 2B) , that this increase in average expression was due to an accumulation of BCRs at the highest observed expression levels (Fig. 2C) , and that the effect was mostly driven by the isotype-switched (i.e. antigen-experienced) compartment (Fig. 2D) . The effect persisted when abundances were defined in a relative rather than absolute fashion, i.e. as a proportion of the total repertoire abundances, eliminating any undesired potential systematic variations in sequencing depth (Fig. 2D ). IGH sequences observed at high abundance are likely to correspond to plasmablasts, so the excess diversity of high-abundance BCRs suggests B-cells differentiate more frequently into plasmablasts in SSc-PAH participants than in healthy subjects.
In order to further elucidate the importance of selection processes acting on proliferating B-cell lineages, we measured what fraction of somatic mutations had become fixed in each lineage, defining a fixed mutation as one that was present in at least 80% of the lineage's sequences. (A lineage was defined as a set of sequences with the same V-segment, same Jsegment, same CDR3 length and 90% CDR3 sequence similarity in single-linkage clustering.)
To eliminate artifacts due to differences in lineage sizes, the analysis was carried out separately for different ranges of lineage sizes. Germline alleles distinct from the reference could be misinterpreted as fixed somatic mutations, but no convincing evidence for the presence of novel germline alleles was found using TIgGER (25) on the present data set. We found that the SSc-PAH cohort on average had a larger fraction of fixed mutations than the healthy cohort across lineage sizes of up to 30 sequences (larger lineages were not consistently found in subjects) (Fig.   2E ). This finding suggests that SSc-PAH lineages have on average undergone more selective sweeps, i.e. have been subject to sustained affinity maturation in response to antigen. One can speculate that the antigens in question are self-antigens, perhaps triggered by molecular mimicry (26) and not necessarily the same for each patient.
To assess whether VDJ rearrangement probabilities or post-rearrangement tolerance checkpoints (27) may be affected in SSc-PAH, we tested for differential expression of Vsegments, which form the most diverse set of germline segments compared to D and J. In order to focus on original VDJ recombination events while removing the effects of clonal expansion and transcript abundance, V-segment counts were defined as a number of lineages (rather than number of sequences or number of transcripts). We found that IGHV2-5 was used at a lower level in SSc-PAH participants (Suppl. Fig. 1D , Fig. 2F ). Note that IGHV2-5 usage was higher for the isotype-switched than for the unswitched compartment (Fig. 2F ), but differential expression between disease and healthy cohorts was observed separately in both compartments, so the effect cannot be solely a consequence of the SSc-PAH-related expansion of the unswitched compartment ( Fig. 2A) . Differential expression was particularly pronounced in the unswitched compartment (Fig. 2F ).
Having identified these B-cell signatures of SSc-PAH, we can ask how they are affected in subjects undergoing B-cell depletion (study arm A). Interestingly, in study arm A, the SSc-PAH-related excess of IgD diversity and deficit in mean IgD mutation load were transiently reversed (Fig. 3A,B) , as was the deficit in IGHV2-5 usage (Fig. 3C ). By contrast, B-cell depletion did not have a clear effect on the fraction of fixed mutations (Fig. 3D) .
Kinetics of repertoire reconstitution
Since we have inferred that the peripheral naïve repertoire is almost entirely wiped out in study group A (Fig. 1B ,C,D,E), we can use that group's longitudinal repertoire data to deduce various rates governing homeostasis of the humoral immune system. Using the number of IgM sequences with zero somatic mutations as a proxy for the naïve diversity of the repertoire, we can express the rate of change of naïve diversity as:
where denotes the number of IgM sequences with mutations, is the generation rate of naïve sequences entering the periphery from the bone marrow, is a mutation probability per unit time, 1 is a class-switch probability per unit time, and 2 is a probability of apoptosis per unit time. Sequences that exit the M 0 diversity by acquiring a mutation will increase the M 1 diversity:
Cells can leave the IgM compartment by either undergoing apoptosis (rate 2 ) or by switching isotype (predominantly to IgA or IgG, rate 1 ). In the latter case they increase the isotypeswitched diversity:
where denotes the number of IgA/IgG sequences with mutations. In equations (1) and (2), we have made the simplifying assumption that the "exit" rates , 1 and 2 applicable to the M 0 diversity are the same for the M 1 diversity; similarly, in equation (3), we have assumed that the rates and 2 governing exits from the S 0 diversity have the same values as in equations (1) and (2) . Indeed, for a first approximation, it seems reasonable to assume that the fraction of a compartment that undergoes apoptosis/mutation/class-switching is roughly independent of the identity of the compartment, particularly if we restrict ourselves to lowly-mutated compartments that likely have a smaller proportion of long-lived memory/plasma cells than more highly mutated compartments.
Given that assessment of diversity using repertoire sequencing is a reliable measurement (Suppl. Fig. S2A ,B), we can determine and ≡ ( + 1 + 2 ) from the B-cell replenishment time course using equation (1), starting at the onset of replenishment (after the more or less extended near-total depletion period). Fitting the linear model for all groups simultaneously as described in Suppl. Fig. S2C (after correcting observed sequence numbers for unseen sequences using the Chao1 estimator (28)) suggested that coefficient varied little between participants whereas coefficient varied significantly, so we fitted the data again using a reduced model with a universal coefficient for all participants and coefficients that were allowed to vary from participant to participant (fits shown in Fig. 4A ). As expected for a steady-state diversity controlled by these generation and exit rates, the diversity to which the M 0 compartment returns after depletion is commensurate with its initial diversity (Suppl. Fig. S2D ).
In steady-state, i.e. in the baseline homeostatic regime, the time derivatives in equations (2) and (3) are zero, so we can deduce = 1 ( ) 0 ( ) (4) and 1 = 0 ( ) 0 ( )+ 0 ( ) (5), followed by 2 = − − 1 (Fig. 4B) . Note that the steady-state form of equation (2) can be generalized to higher mutation loads:
, meaning the distribution of mutation loads in the IgM compartment should be an exponential decay, which is roughly obeyed in our data (Suppl. Fig. S2E ; note that the isotypeswitched compartment displayed in Suppl. Fig. S2F follows a contrasting distribution peaked at a non-zero mutation load). Since the data shows a hint that there may be a slight excess of highlymutated IgM sequences compared to the exponential law, which may be attributable to longlived IgM memory cells and plasmablasts that do not follow our simple system of equations above, we decided to determine based on only M 0 and M 1 using equation (4) rather than fitting the entire distribution M x using equation (6) . The resulting sequence generation, mutation, classswitch and apoptosis rates (Fig. 4B) show that apoptosis due to the absence of activation by any cognate antigen is the most important factor limiting the naïve diversity; once a cell gets activated by a cognate antigen, a mutation event is more likely to occur first than a class-
If one wanted to predict the time course of naïve B-cell replenishment after the first depleted time point, one would need three pieces: the time to onset of replenishment, the generation rate , and the exit rate . Now, appeared to be near-"universal" between participants, was found to be strongly correlated with the baseline naïve diversity (Fig. 4C ), and the time to onset of replenishment was found to be inversely correlated with baseline diversity (Fig. 4D ). These observations suggest the intriguing possibility of predicting depletion/replenishment time courses from baseline measurements alone.
Similarities and perturbations of the reconstituted repertoire compared to baseline
We sought to assess which features of the BCR repertoire are elastic or plastic under Bcell depletion. We found that there is a clear stereotypy to the repertoire that is recovered after depletion: isotype usages, VDJ combination usages and mutation-load histograms show a marked similarity to their baseline profiles that is only temporarily lost after depletion (Fig. 5A ).
The mutation load profiles show that high mutation loads do not necessitate a lifetime of pathogen-induced affinity maturation, but are recovered within months -so any subsequent improved immune responses are presumably not generated by B-cell lineages acquiring more and more mutations ad infinitum, but rather by adding breadth to the phylogenetic tree.
Frequencies of VDJ segment combinations (defined here as the number of distinct IGH sequences with a given combination) exhibited a similarity between participants at baseline that was lost in depletion but recovered at the monitoring endpoint (Suppl. Fig. S3A ). The set of amino acid (AA) changes in the repertoire also showed a greater degree of inter-participant similarity when repertoires were full (baseline or endpoint) rather than depleted (Suppl. Fig.   S3B ). This observation suggests intrinsic biases of the somatic hypermutation machinery that are conserved between participants (29), contrasted with participant-by-participant idiosyncrasy of the mutations exhibited by the (presumably highly pathogen-specific) plasmablasts that remain during depletion. While VDJ usages, isotype usages and mutation histograms were highly elastic -demonstrating that mechanisms of diversity generation are intact after B-cell depletion -only a fraction of AA changes present at baseline were observed to return by the endpoint (Fig. 5A , "specific mutations").
Next, we disentangled the B-cell populations that replenish the repertoire. First, we contrast antigen-experienced cells with naïve cells (Fig. 5B,C) , focusing on their contributions to the total transcript abundances, which should be a proxy for rough protein abundances. We observe two distinct phenotypes: in certain participants (SR2 and SR4), the first post-depletion repertoire consists almost entirely of antigen-experienced transcripts (Fig. 5B) , whereas in most participants (SR1, SR3, SR5, SR6) the naïve and antigen-experienced compartments recover simultaneously ( and IgG2 isotypes beyond baseline levels (Fig. 6A) ; in subject SR2 there was also a marked increase in IGH sequences with high somatic mutation loads (range 6-9 mutations in the sequenced region, Fig. 6B ).
In order to characterize the role of B-cell clonal proliferation in the replenishment of the repertoire, we assigned lineages to 3 bins depending on their degree of expansion ( to each other at the last time point was comparable to baseline (SR1, SR5 in Fig. 6C ).
Discussion
We have characterized the role of B-cells in SSc-PAH at the level of the B-cell receptor.
We identified an anomaly in the process of VDJ recombination, namely underuse of the IGHV2-5 segment (particularly in the isotype-unswitched compartment, Fig. 2F ) and noted an interesting bimodal effect at the extremes of peripheral B-cell development: SSc-PAH participants displayed elevated proportions of both naïve BCRs ( Fig. 2A) and of highly secreted antigenexperienced BCRs (Fig. 2B,C,D) . It is worth noting that the presence of any infection at baseline would have made subjects ineligible to participate in the present study, so that any excess proportion of plasmablasts cannot be the result of current infection. Instead, the excess may suggest a sustained immune response against self-antigens, a hypothesis which is further corroborated by the observation of an increased proportion of near-fixed somatic mutations likely to arise from clonal selection (Fig. 2E) . Certain of these disease signatures are clearly transiently reversed by CD20 + B-cell depletion, namely the IGHV2-5 gene usage (Fig. 3C ) and the naïve proportion (Fig. 3A,B) .
The observation of B-cell depletion in one group of study subjects ( Fig. 1 ) allowed us to measure rates governing BCR diversity generation and dissipation in humans in vivo (Fig. 4A,B) , demonstrating the high frequency of apoptosis of naïve cells compared to activation, as well as the precedence of somatic mutation over class-switch recombination in activation. More importantly, these measurements, combined with trends relating replenishment rates and depletion durations to baseline information (Fig. 4C,D) , constitute a proof of principle for the prediction of immunologic depletion and replenishment time courses from baseline information alone. We compared the reconstituted repertoire to the baseline repertoire and noted a remarkable resiliency of summary properties such as VDJ frequencies, mutation histograms and isotype frequencies (Fig. 5A) , indicating that the diversity generation mechanisms of VDJ recombination, somatic hypermutation and class-switch recombination are intact after depletion and able to regenerate a normal B-cell repertoire in a timespan of months.
We also dissected the mechanism of B-cell replenishment after depletion. We found that release of antigen-experienced cells into the periphery -likely plasma cells released from the bone marrow -does (Fig. 5B ) or does not (Fig. 5C ) precede the onset of naïve repopulation depending on the individual. Antibody repertoire sequencing exposed the lineage structure of the recovering B-cell ensemble, revealing subject-to-subject heterogeneity in the pattern of clonal expansion after depletion (Fig. 6C ).
Materials and Methods
Protocols were approved by the Institutional Review Board at Stanford University and at all Autoimmunity Center of Excellence sites providing samples for this study; participants gave informed consent. IGH repertoires were obtained using previously published protocols (31, 32) with small modifications, via the following steps: RT with IGH constant domain specific primers containing random barcodes (Table S2) 
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IGH repertoire sequencing
The assay used in the present study proceeded in the following steps, which were a minor variation of published protocols (22, 31, 32) : PBMC isolation from whole blood using a Ficoll 
Data pre-processing
Data pre-processing was carried out in a manner analogous to a previous study (22) . First, we carried out the following steps of the pRESTO (33) nucleotide sequence with a Hamming distance cutoff of 0.1 times the CDR3 length (using the R package 'stringdist' (36)). Snakemake (37) was used to manage computational workflows.
UniFrac calculation
UniFrac (21) distances were computed as described in a previous antibody repertoire study (22) , subsampling each repertoire/time-point to a depth of 10 4 distinct sequences if the total number of available sequences exceeded that number.
Mutation analysis
Reported nucleotide mutation counts were based on mismatches between each observed sequence and its inferred germline sequence. Reported AA changes for the V-segment were extracted from IMGT/HighV-QUEST output.
Plots
For Fig. 2C , abundance histograms were generated with a bin size of 20 and the lowest bin (which was the dominant one) was omitted from the plot to allow the tail of the distribution to be visualized. In Fig. 2D ,F, points straddling the lower edge of the panel correspond to the value 0, which cannot be rendered on the logarithmic scale. 
Statistical tests
